Long-term side effects: Krystal says that when used ... Coulter-Scott continues to get routine booster ketamine infusions and also takes antidepressants and talks to a therapist.

Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...

Bryan Johnson is a biohacker on a mission to conquer death and has been injecting ketamine into his system to see how it ...

If you are thinking about receiving ketamine infusion therapy, you'll want to consider some side effects beforehand. Also, if you're dealing with a mental health condition, you might not be ...

Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

The anesthetic ketamine is being hailed as a breakthrough therapy for people with post-traumatic stress disorder (PTSD), treatment-resistant depression and other mood disorders. But the drug does have ...

The anesthetic ketamine is being hailed as a breakthrough therapy for people with post-traumatic stress disorder (PTSD), treatment-resistant depression and other mood disorders.

Medicare does not typically cover ketamine infusions for mental health ... Due to the risks of certain side effects of the drug, including abuse and misuse, a person must administer the nasal ...

“Despite extensive studies on IV ketamine infusions, there are gaps in understanding the ... Participants also reported less of the known side effects associated with intravenous ketamine ...

The American Society of Anesthesiologists has issued new guidance on ketamine administration for patients suffering from post-traumatic stress disorder, treatment-resistant depression and other mood ...

Scientists think ketamine relieves depression and anxiety by altering GluN1-2B-2D’s movements, but the effects can vary ...

IntroductionMajor depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing ...